NCT00806013View on ClinicalTrials.gov

Study the Effects of CYP2C Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Glipizide

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2008

Study Completion Date

December 31, 2008

Conditions
Healthy
Trial Locations (1)

201203

The second hospital to Liaoning University of TCM, Shenyang

Sponsors
All Listed Sponsors
lead

Chinese Academy of Sciences

OTHER_GOV

NCT00806013 - Study the Effects of CYP2C Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Glipizide | Biotech Hunter | Biotech Hunter